Minnesota HF 646: Counterfeit drug investigation requirements established.

Status: Introduction and first reading, referred to Health and Human Services Policy (as of 2019-02-04)

State: Minnesota · Session: 2019-2020 · Bill: HF 646

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Lesch, Albright, Zerwas

View Minnesota HF 646 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.